Molecules/ADENOVIRUS TYPE 26 ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN

ADENOVIRUS TYPE 26 ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN

Molecular Identity

Vaccine componentApprovedFirst approved 2021

Mechanism of action: Spike glycoprotein vaccine antigen

Molecular Formula

0.00

Molecular Weight

g/mol

ADENOVIRUS TYPE 26 ENCODING SARS-COV-2 SPIKE GLYCOPROTEINJCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ADENOVIRUS TYPE 26 ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN

Loading drug network...